Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.44 |
| ▸ | RECQL | P46063 | 1/20 | 0.44 |
| ▸ | ACHE | P22303 | 1/20 | 0.43 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.42 |
| ▸ | ABAT | P80404 | 1/20 | 0.41 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.40 |
| ▸ | TYR | P14679 | 1/20 | 0.38 |
| ▸ | CASP1 | P29466 | 1/20 | 0.37 |
| ▸ | ESR2 | Q92731 | 4/20 | 0.36 |
| ▸ | ESR1 | P03372 | 3/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.36 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.36 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.36 |
| ▸ | HTR1D | P28221 | 1/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.36 |
| ▸ | HTR7 | P34969 | 1/20 | 0.36 |
| ▸ | HTR3A | P46098 | 1/20 | 0.36 |
| ▸ | HTR6 | P50406 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4394169 | 0.82 | ESR2 (0.46) | TSHRCYP3A4RECQLACHEABAT | |
| SCHEMBL6266185 | 0.81 | CYP3A4 (0.47) | TSHRCYP3A4RECQLACHETYR | |
| SCHEMBL12525643 | 0.79 | TAAR1 (0.50) | TSHRCYP3A4RECQLACHETAAR1 | |
| SCHEMBL1665310 | 0.79 | SHBG (0.47) | TSHRCYP3A4RECQLACHETYR | |
| SCHEMBL31305638 | 0.79 | CYP3A4 (0.50) | TSHRCYP3A4RECQLACHETYR | |
| SCHEMBL2015021 | 0.79 | CYP3A4 (0.50) | TSHRCYP3A4RECQLACHETYR | |
| SCHEMBL1663206 | 0.77 | CYP3A4 (0.44) | TSHRCYP3A4RECQLACHETYR | |
| SCHEMBL19735194 | 0.77 | CYP3A4 (0.44) | TSHRCYP3A4RECQLACHETYR | |
| SCHEMBL111635 | 0.76 | TAAR1 (0.68) | CYP3A4TAAR1CYP1A2HSD17B10TDP1 | |
| SCHEMBL772938 | 0.76 | EGFR (0.50) | CYP3A4ABATENPP2TYRCYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-1293074-C | Arylindenopyridines with PDE inhibiting activity | ORTHO MCNEIL PHARM INC (US) | 2007-01-03 | — | — | CN | claimed |
| CN-1516698-A | Arylindenopyridines with PDE inhibiting activity | 奥索・麦克尼尔药品公司 | 2004-07-28 | — | — | CN | claimed |
| US-20230364032-A1 | USE OF 2-HOBA TO TREAT ATHEROSCLEROSIS | VANDERBILT UNIVERSITY | 2023-11-16 | — | — | US | disclosed |
| US-20230355549-A1 | METHOD OF PREVENTING KIDNEY INJURY DISRUPTION OF INTESTINAL LYMPHATICS | VANDERBILT UNIVERSITY | 2023-11-09 | — | — | US | disclosed |
| US-20230330049-A1 | COMPOSITIONS AND METHODS OF USE OF GAMMA-KETOALDHEYDE SCAVENGERS FOR TREATING, PREVENTING OR IMPROVING FIBROSIS OF THE LIVER | MTI BIOTECH, INC. | 2023-10-19 | — | — | US | disclosed |
| US-11696903-B2 | Compounds and methods for scavenging dicarbonyl electrophiles | VANDERBILT UNIVERSITY (US) | 2023-07-11 | — | — | US | disclosed |
| US-20180153827-A1 | COMPOSITIONS AND METHODS OF USE OF GAMMA-KETOALDEHYDE SCAVENGERS FOR TREATING, PREVENTING OR IMPROVING NONALCOHOLIC FATTY LIVER DISEASE (NAFLD), NASH, ALD OR CONDITIONS RELATED TO THE LIVER | MTI BIOTECH, INC. | 2018-06-07 | — | — | US | disclosed |
| US-20150265584-A1 | LEVUGLANDIN ADDUCTS HISTONE H4 IN A CYCLOOXYGENASE-2-DEPENDENT MANNER, ALTERING ITS INTERACTION WITH DNA | NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR | 2015-09-24 | — | — | US | disclosed |
| US-20140256774-A1 | METHODS FOR TREATING INFLAMMATION AND HYPERTENSION WITH GAMMA-KETOALDEHYDE SKAVENGERS | VANDERBILT UNIVERSITY (US) | 2014-09-11 | — | — | US | disclosed |
| US-8822542-B2 | Isoketal scavengers and mitigation of disorders involving oxidative injury | VANDERBILT UNIVERSITY (US) | 2014-09-02 | — | — | US | disclosed |
| US-20120157501-A1 | ISOKETAL SCAVENGERS AND MITIGATION OF DISORDERS INVOLVING OXIDATIVE INJURY | VANDERBILT UNIVERSITY | 2012-06-21 | — | — | US | disclosed |
| WO-2010024430-A1 | 2,4-DIAMINOPYRIMIDINE COMPOUND | アステラス製薬株式会社 (JP) | 2010-03-04 | — | — | WO | disclosed |
| CN-1293074-C | Arylindenopyridines with PDE inhibiting activity | ORTHO MCNEIL PHARM INC (US) | 2007-01-03 | — | — | CN | disclosed |
| CN-1516698-A | Arylindenopyridines with PDE inhibiting activity | 奥索・麦克尼尔药品公司 | 2004-07-28 | — | — | CN | disclosed |
| EP-0915935-B1 | 4,7-DICHLORORHODAMINE DYES | PERKIN ELMER CORP (US) | 2001-03-07 | — | — | EP | disclosed |
| US-6025505-A | FLUORESCENT LABELING PROBES FOR IMMUNOASSAYS, DNA SEQUENCING, DETECTING PRODUCTS OF POLYMERASE CHAIN REACTIONS | THE PERKIN-ELMER CORPORATION (US) | 2000-02-15 | — | — | US | disclosed |
| US-6017712-A | NUCLEOTIDE LABELED WITH XANTHENE DYE HAVING NARROWER EMISSION SPECTRUM AND WITH ABSORPTION SPECTRUM SHIFTED TO THE RED; FOR MOLECULAR PROBES AND IN NUCLEIC ACID SEQUENCING | APPLIED BIOSYSTEMS, LLC | 2000-01-25 | — | — | US | disclosed |
| EP-0915935-A1 | 4,7-DICHLORORHODAMINE DYES | The Perkin-Elmer Corporation (US) | 1999-05-19 | — | — | EP | disclosed |
| US-5847162-A | 4, 7-Dichlororhodamine dyes | THE PERKIN ELMER CORPORATION (US) | 1998-12-08 | — | — | US | disclosed |
| WO-1997049769-A1 | 4,7-DICHLORORHODAMINE DYES | THE PERKIN-ELMER CORPORATION (US) | 1997-12-31 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140256774-A1 | METHODS FOR TREATING INFLAMMATION AND HYPERTENSION WITH GAMMA-KETOALDEHYDE SKAVENGERS | AKR1B1, NFKBIA, PTGS2 | TSHR 4489/4885CYP3A4 1399/4885RECQL 4508/4885 |
| US-20120157501-A1 | ISOKETAL SCAVENGERS AND MITIGATION OF DISORDERS INVOLVING OXIDATIVE INJURY | PDXK, KYNU, FN3K | TSHR 3896/4885CYP3A4 1643/4885RECQL 1831/4885 |
| US-20230364032-A1 | USE OF 2-HOBA TO TREAT ATHEROSCLEROSIS | HACL2, APOB, OAT | TSHR 3707/4885CYP3A4 4366/4885RECQL 2071/4885 |
| US-20230355549-A1 | METHOD OF PREVENTING KIDNEY INJURY DISRUPTION OF INTESTINAL LYMPHATICS | FABP2, SI, MLN | TSHR 4381/4885CYP3A4 3794/4885RECQL 4076/4885 |
| US-20230330049-A1 | COMPOSITIONS AND METHODS OF USE OF GAMMA-KETOALDHEYDE SCAVENGERS FOR TREATING, PREVENTING OR IMPROVING FIBROSIS OF THE LIVER | GGT1, GGH, AKR7A2 | TSHR 4674/4885CYP3A4 2680/4885RECQL 3676/4885 |
| US-20150265584-A1 | LEVUGLANDIN ADDUCTS HISTONE H4 IN A CYCLOOXYGENASE-2-DEPENDENT MANNER, ALTERING ITS INTERACTION WITH DNA | H1-2, H1-4, H1-3 | TSHR 4637/4885CYP3A4 708/4885RECQL 612/4885 |
| US-11696903-B2 | Compounds and methods for scavenging dicarbonyl electrophiles | OGG1, LGMN, GLO1 | TSHR 4757/4885CYP3A4 1024/4885RECQL 1196/4885 |
| US-20180153827-A1 | COMPOSITIONS AND METHODS OF USE OF GAMMA-KETOALDEHYDE SCAVENGERS FOR TREATING, PREVENTING OR IMPROVING NONALCOHOLIC FATTY LIVER DISEASE (NAFLD), NASH, ALD OR CONDITIONS RELATED TO THE LIVER | CPT1A, AKR7A2, FABP1 | TSHR 4555/4885CYP3A4 1113/4885RECQL 2753/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.